Acorah Software Products - Accounts Production15.0.600truetrue31 May 20231 June 2022falsetrueNo description of principal activity1 June 202331 May 202431 May 202412601249Mr ISmail Hamdulayiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure126012492023-05-31126012492024-05-31126012492023-06-012024-05-3112601249frs-core:CurrentFinancialInstruments2024-05-3112601249frs-bus:PrivateLimitedCompanyLtd2023-06-012024-05-3112601249frs-bus:FilletedAccounts2023-06-012024-05-3112601249frs-bus:Micro-entities2023-06-012024-05-3112601249frs-bus:EntityHasNeverTraded2023-06-012024-05-3112601249frs-bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3112601249frs-bus:Director12023-06-012024-05-31126012492022-05-31126012492023-05-3112601249frs-core:CurrentFinancialInstruments2023-05-31
Registered number: 12601249
Immunehealth Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2024
Immunehealth Ltd
Balance Sheet
As At 31 May 2024
Balance Sheet
Registered number: 12601249
2024
2023
£
£
Creditors: Amounts Falling Due Within One Year
(2,321)
(1,961)
NET CURRENT LIABILITIES
(2,321)
(1,961)
TOTAL ASSETS LESS CURRENT LIABILITIES
(2,321)
(1,961)
NET LIABILITIES
(2,321)
(1,961)
CAPITAL AND RESERVES
(2,321)
(1,961)
Notes
1.General Information
Immunehealth Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12601249. The registered office is 33 ARBUTUS DRIVE, COOMBE DINGLE, BRISTOL, AVON, BS9 2PW.
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.